Target Healthcare REIT (LON:THRL) Shares Cross Above 50-Day Moving Average – Time to Sell?

Target Healthcare REIT (LON:THRL – Get Free Report) passed above its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of GBX 112.13 and traded as high as GBX 115.80. Target Healthcare REIT shares last traded at GBX 114.60, with a volume of 1,270,746 shares changing hands.

Analyst Ratings Changes

Separately, Jefferies Financial Group reissued a “buy” rating and issued a GBX 124 price objective on shares of Target Healthcare REIT in a research report on Thursday, October 15th. One research analyst has rated the stock with a Buy rating. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of GBX 124.

Check Out Our Latest Research Report on THRL

Target Healthcare REIT Price Performance

The firm’s 50 day moving average is GBX 112.13 and its two-hundred day moving average is GBX 109.68. The firm has a market capitalization of £713.27 million, a P/E ratio of 8.63, a PEG ratio of 1.48 and a beta of 0.71.

Target Healthcare REIT (LON:THRL – Get Free Report) last posted its quarterly earnings results on Wednesday, September 23rd. The company reported GBX 13.32 earnings per share (EPS) for the quarter. Target Healthcare REIT had a net margin of 114.60% and a return on equity of 11.03%. Analysts anticipate that Target Healthcare REIT will post 6.22 EPS for the current fiscal year.

Target Healthcare REIT Company Profile

(Get Free Report)

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.

Further Reading

Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.